Patent ID: 8097604

Claim:
A medicament consisting of an active ingredient combination and one or more conventional auxiliary substances, wherein the active ingredient combination consists of at least one insulin sensitizer and at least one an antiandrogenic gestagen component, wherein the antiandrogenic gestagen component is chlormadinone acetate or selected from the group consisting of: a) 3α-hydroxy-chlormadinone acetate; b) 3β-hydroxy-chlormadinone acetate; c) a mixture of a) and b) in any desired mixing ratio; d) 3α-hydroxy-17α-acetoxy-5β-pregnan-20-one; e) 3β-hydroxy-17α-acetoxy-5β-pregnan-20-one; f) a mixture of d) and e) in any desired mixing ratio; g) a mixture of a) and/or b) with d) and/or e) in any desired mixing ratio; h) a mixture of chlormadinone acetate (CMA) with a) and/or b) in a mixing ratio of 10 to 90 wt. % of CMA and 90 to 10 wt. % of a) and/or b), relative to the complete mixture; i) a mixture of chlormadinone acetate with d) and/or e) in a mixing ratio of 10 to 90 wt. % of chlormadinone acetate and 90 to 10 wt. % of d) and/or e), relative to the complete mixture; j) a mixture of chlormadinone acetate with c) and f) in a mixing ratio of 10 to 90 wt. % of chlormadinone acetate and 90 to 10 wt. % of c) and f), relative to the complete mixture; k) a mixture of chlormadinone acetate with g) in a mixing ratio of 10 to 90 wt. % of CMA and 90 to 10 wt. % of g), relative to the complete mixture; and mixtures thereof, wherein components d), e) or f), listed above, are not used as the sole gestagen or as the gestagen mixture in f), but are instead used only in combination with a further, above-listed gestagen.